Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 8, pp. 1258-1266
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 4, 2018
- Revision received March 29, 2019
- Accepted June 19, 2019
- Published first June 25, 2019.
Article Versions
- Previous version (June 25, 2019 - 06:56).
- Previous version (July 11, 2019 - 05:54).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Lulu Shao1,2,
- Weizhou Hou1,
- Nicole E. Scharping3,4,
- Frank P. Vendetti5,
- Rashmi Srivastava1,2,
- Chandra Nath Roy1,2,
- Ashley V. Menk3,4,
- Yiyang Wang3,4,
- Joe-Marc Chauvin4,
- Pooja Karukonda5,
- Stephen H. Thorne1,
- Veit Hornung6,
- Hassane M. Zarour4,
- Christopher J. Bakkenist5,
- Greg M. Delgoffe3,4, and
- Saumendra N. Sarkar1,2,4,*
- 1Cancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
- 2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- 3Tumor Microenvironment Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
- 4Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- 5Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- 6Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
- ↵*Corresponding Author:
Saumendra N. Sarkar, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, UPMC Hillman Cancer Center, Suite 1.8, Pittsburgh, PA 15213. Phone: 412-623-7720; Fax: 412-623-7715; E-mail: saumen{at}pitt.edu
August 2019
Volume 7, Issue 8
Volume 7, Issue 8
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
Jump to section
Advertisement